glp 1 agonist bone density Frontiers Effects of Glucagon-Like Peptide-1 receptor
Description
Both Ozempic, made by Novo Nordisk, and Mounjaro, made by Eli Lilly, are FDA-approved to treat Type 2 diabetes, but some doctors prescribe the medication "off-label" for weight loss, as is permissible by the FDA
We also need to evaluate other tools, such as the FRAX and trabecular bone score (TBS) in this specific population
Effects on Non-Alcoholic Fatty Liver Disease Non-alcoholic fatty liver disease (NAFLD) is a metabolic stress liver injury closely related to IR and genetic variations
Additional claims involve vision-related injuries that patients say developed after sustained use of GLP-1 drugs
A doctor can adjust the dose to balance results with side effects
R.ArriS.GershB
